Fact-checked by Grok 2 weeks ago

Palytoxin

Palytoxin (PTX) is a highly potent and structurally complex marine toxin, recognized as one of the most lethal non-peptide natural substances known to science, with a molecular formula of C<sub>129</sub>H<sub>223</sub>N<sub>3</sub>O<sub>54</sub> and a molecular weight of approximately 2,680 Da, featuring a 115-carbon backbone adorned with 64 chiral centers and numerous hydroxyl groups. Originally isolated in 1971 from the Hawaiian zoanthid coral Palythoa toxica, it is primarily produced by zoantharians of the genus Palythoa and dinoflagellates of the genus Ostreopsis, with potential contributions from cyanobacteria like Trichodesmium. Its structure was fully elucidated in 1981–1983 through collaborative efforts involving Japanese and American researchers, revealing an unprecedented polyhydroxylated and partially cyclic architecture that confers extreme stability and bioactivity. The toxin's primary mechanism of action involves binding to the Na<sup>+</sup>/K<sup>+</sup>-ATPase pump on cell membranes, transforming it into a non-selective cation channel that disrupts sodium and potassium ion gradients, leading to rapid membrane depolarization, calcium influx, cytoskeletal alterations, and ultimately cell lysis or necrosis. This results in severe systemic effects, including rhabdomyolysis, cardiac arrhythmias, respiratory failure, and hemolysis, with toxicity manifesting across multiple exposure routes: ingestion (e.g., contaminated seafood like crabs or fish), inhalation (e.g., aerosolized algal blooms), and dermal contact (e.g., handling aquarium corals). In animal models, PTX exhibits extraordinary potency, with median lethal doses (LD<sub>50</sub>) as low as 0.15 μg/kg intraperitoneally in mice and 25–450 ng/kg intravenously in rabbits, though oral toxicity is lower (LD<sub>50</sub> >40 μg/kg in rats due to poor absorption). Human cases, often linked to Ostreopsis blooms or home aquariums, present with symptoms such as intense pain, paresthesia, muscle weakness, and in severe instances, fatalities, as documented in outbreaks in the Philippines, Madagascar, and Brazil from contaminated seafood, and isolated incidents in Europe and the US from coral handling. Ecologically, PTX serves as a mechanism in producing organisms and bioaccumulates through food webs, contributing to harmful algal blooms (Ostreopsis spp.) that affect fisheries, tourism, and by causing mass mortalities in , , and . Analogs like ostreocin-D, ovatoxin-a, and mascarenotoxin-a, sharing similar structures and toxicities, expand the group's environmental footprint, with recent research highlighting risks from chronic low-level exposure potentially linked to neurodegenerative effects. Despite its potency, no specific exists; treatment remains supportive, emphasizing the need for improved detection methods, such as liquid chromatography-mass spectrometry, and public awareness to mitigate emerging threats from and climate-driven algal proliferations.

History

Folklore and early observations

In traditional Hawaiian folklore, the substance known as "limu make o Hana," or "deadly seaweed of Hana," was described as a highly poisonous marine growth found in tide pools near the village of Hana on Maui. According to the legend, this toxic entity originated from the remains of a defeated shark-man warrior whose ashes were cast into the sea, causing it to manifest as a lethal moss or seaweed that lined the pool walls and could kill instantly upon contact or if used to tip spears. Later scientific investigations associated this folklore with colonies of the zoanthid Palythoa toxica covering rocks in Hawaiian tide pools, linking the rapid deaths described to exposure to palytoxin. Early 20th-century reports documented unexplained poisonings from consuming in tropical regions, often attributed to clupeoid species such as sardines and herrings that caused sudden, severe symptoms including and death shortly after ingestion. These incidents were widespread but lacked chemical identification, with cases reported across the and as early as the 1800s, though intensified observations occurred in the mid-1900s. In a comprehensive review, Bruce W. Halstead analyzed 87 documented cases of clupeoid toxicity up to 1967, noting the rapid onset of symptoms like numbness, respiratory distress, and fatalities within minutes to hours, yet no specific toxin was isolated at the time. In during the 1960s, observations of toxicity in , particularly Alutera scripta, preceded the formal isolation of palytoxin, with reports of fatalities linked to consumption of the fish's viscera. Researchers identified a potent heat-stable in the gut extracts of these , initially named aluterin, which caused symptoms resembling those in the accounts, including muscle spasms and cardiovascular collapse in affected animals and humans. These findings suggested from symbiotic zoanthids like Palythoa tuberculosa, though the exact compound was not fully characterized until later studies connected it to palytoxin.

Scientific discovery

Palytoxin was first isolated in 1971 by chemists Richard E. Moore and Paul J. Scheuer at the University of Hawaii from the zoanthid coral Palythoa toxica collected in Hana Bay, Maui. Motivated by Hawaiian folklore accounts of the coral's extreme toxicity, their extraction process involved grinding the coral, followed by purification using ion-exchange chromatography and gel filtration, yielding a water-soluble, heat-stable compound that resisted proteolysis and was not a peptide. Initial characterization revealed it to be a novel non-protein marine toxin with unprecedented potency, named "palytoxin" after its source organism. Prior to this isolation, a 1969 report by Japanese researchers Yasushi Hashimoto, Nobuaki Fusetani, and Shigeru Kimura at the University of Tokyo described a similar potent toxin, dubbed "aluterin," extracted from the digestive tracts of the filefish Alutera scripta. They hypothesized that the filefish acquired the toxin by consuming the zoanthid Palythoa tuberculosa, linking it to cases of fish poisoning resembling ciguatera. This discovery prompted international interest and collaborative efforts between the Hawaiian and Japanese research groups to compare the toxins and confirm their identity. By 1972, further assays confirmed palytoxin's exceptional lethality across animal models, with an intravenous LD<sub>50</sub> of 0.15 μg/kg in mice, surpassing most known non-peptide toxins. Early pharmacological investigations in the 1970s, notably in 1974, demonstrated its rapid effects on cardiovascular and neuromuscular systems in preparations, such as in at concentrations as low as 0.1 ng/mL and in frog heart at 10–100 ng/mL. These studies solidified palytoxin's reputation as one of the most toxic non-peptide substances identified to date.

Structure determination

The determination of palytoxin's structure presented significant challenges due to its large size, featuring a 115-carbon chain backbone, multiple rings, and chiral centers that could theoretically yield over 10^21 stereoisomers, compounded by the molecule's chemical instability under analytical conditions. Early efforts focused on partial characterization; in 1975, Richard E. Moore and colleagues proposed a partial emphasizing the γ263 based on spectroscopic analysis of degradation products from Hawaiian specimens. A major breakthrough occurred in 1981 when two independent groups reported the gross structure of palytoxin. Yoshimasa Hirata and colleagues at , using (NMR) , chemical degradation, and on samples from Okinawan tuberculosa, deduced a complex polyhydroxylated structure with 115 carbon atoms, including a series of cyclic ethers and functionalities. Simultaneously, Moore's team at the confirmed a similar connectivity through complementary degradation studies and UV-visible , establishing the as C129H223N3O54. The remained unresolved until 1982–1983, when Hirata's group and Yoshito Kishi's team at employed advanced NMR techniques and synthetic fragment comparisons to assign configurations at the 64 chiral centers, fully elucidating the structure. In 1980, Ronald D. Macfarlane, Daisuke Uemura, Katsuhiro Ueda, and Yoshimasa Hirata further validated the structure using californium-252 plasma desorption , which provided high-molecular-weight ions consistent with the proposed formula despite the compound's lability. The ultimate confirmation came through total synthesis; Kishi's group achieved this in 1989 after more than 100 synthetic steps starting from simple precursors, yielding palytoxin and in low overall (approximately 0.0006%), underscoring the formidable synthetic barriers posed by the molecule's size and stereochemical complexity. This synthesis not only verified the assigned structure but also highlighted innovative strategies like the Nozaki-Hiyama-Kishi reaction for carbon-carbon bond formation in polyether assembly.

Chemistry

Molecular structure

Palytoxin is characterized by a linear polyhydroxylated aliphatic chain serving as its backbone, consisting of 115 contiguous carbon atoms along with eight methyl branches, resulting in a total of 129 carbon atoms in the molecular formula C₁₂₉H₂₂₃N₃O₅₄. This structure features 64 stereocenters, contributing to its immense structural complexity, and includes cyclic ethers that form part of the polyether framework. Its molecular weight is 2,680 Da. These elements, including the abundance of hydroxyl groups (approximately 40–42), confer amphipathicity to palytoxin, with hydrophilic polyol regions alternating with lipophilic sections dominated by the cyclic ethers and alkyl chains. Several analogues of palytoxin have been identified, sharing the core polyhydroxylated polyether architecture but differing in lengths, hydroxyl positions, and patterns. Ostreocins, produced by the Ostreopsis siamensis, include ostreocin-D, which features modifications such as the absence of methyl groups at positions 3 and 26, a deoxy group at position 19, and an additional hydroxyl at position 42 compared to palytoxin. Ovatoxins, first characterized in the from Ostreopsis ovata, exhibit shorter terminal alkyl chains and variations in the number and placement of hydroxyl groups, resulting in slightly lower molecular weights around 2,648–2,650 Da.

Physical and chemical properties

Palytoxin is isolated as a white, amorphous, hygroscopic powder. Due to its amphiphilic nature, with a long lipophilic carbon chain and 40 hydrophilic hydroxyl groups, palytoxin is highly soluble in and polar solvents such as and . It demonstrates thermal up to 100°C, remaining unaffected by , and maintains integrity in neutral aqueous solutions over extended periods, though it undergoes rapid degradation in strong acids or bases. For optimal storage, solutions exceeding 50% at 5–8 are recommended to preserve , according to 2025 investigations into solvent and temperature effects. Neutralization can be achieved with 0.1% (household ), which effectively inactivates the toxin upon exposure. Palytoxin exhibits characteristic absorption maxima at 233 nm and 263 nm, attributable to its conjugated chromophores, enabling its detection via methods like liquid chromatography-mass spectrometry (LC-MS/MS).

Occurrence

Producing

Palytoxin was first isolated from zoantharian corals of the genus , particularly species such as P. toxica and P. tuberculosa, which are found in tropical and subtropical environments. These soft corals, often colonial anemone-like , biosynthesize palytoxin as a defensive compound, with concentrations varying by species and location; for instance, P. toxica from waters yielded the initial extracts in the 1970s. species maintain symbiotic relationships with dinoflagellates, such as , which may contribute to the coral's nutrient acquisition but are not directly implicated in toxin production. Dinoflagellates of the genus Ostreopsis, including O. ovata and O. siamensis, are major producers of palytoxin analogues known as ovatoxins, which share structural similarities with palytoxin but differ in side-chain modifications. These benthic generate these toxins during blooms, which have been documented in the and Pacific regions, leading to accumulation in associated . For example, O. cf. ovata strains from French Mediterranean coasts produce multiple ovatoxins (e.g., OVTX-a, OVTX-b) alongside putative palytoxin, confirmed through liquid chromatography-mass spectrometry analyses. Other organisms capable of producing palytoxin or its derivatives include the cyanobacterium , where palytoxin and 42-hydroxy-palytoxin were first detected in bloom samples from lagoons in 2011. Additionally, the benthic Prorocentrum borbonicum was identified in 2022 as a producer of 42-hydroxy-palytoxin along the Colombian coast, marking its first record in that region and expanding the known microbial sources of palytoxin-like compounds. These findings highlight the diverse phylogenetic origins of palytoxin across microbes and invertebrates.

Environmental distribution and bioaccumulation

Palytoxin exhibits a widespread distribution in marine environments, predominantly in tropical and subtropical waters of the region, including (such as Bay and ), (southern islands), the , (Port ), , , and . It has also been documented in temperate areas, such as the (notably the NW region), the Atlantic Ocean, the , the China Sea, the , and the . These occurrences are primarily associated with benthic and epiphytic dinoflagellates like Ostreopsis species, which thrive in shallow, sheltered coastal zones including harbors and estuaries with low to moderate water flow. In the , studies have reported an expansion of Ostreopsis blooms linked to ocean warming, which has increased the frequency and geographical range of palytoxin presence, particularly in coastal and high-latitude regions previously less affected. This climate-driven proliferation heightens the risk of toxin dissemination into broader ecosystems. Bioaccumulation of palytoxin occurs through trophic transfer in marine food webs, beginning with uptake by herbivorous and filter-feeding organisms that consume toxin-producing microalgae such as Ostreopsis species or, less commonly, zoanthids like Palythoa. Shellfish, including mussels (Mytilus galloprovincialis) and oysters (Crassostrea gigas), accumulate the toxin primarily in their hepatopancreas, digestive glands, and gonads, with documented levels reaching up to 230 µg palytoxin equivalents per kg in mussels during blooms. Crabs, particularly xanthid species like Demania reynaudii, sequester high concentrations in their hepatopancreas through ingestion of contaminated prey. The toxin then biomagnifies in predatory organisms, such as filefish (Melichtys vidua), parrotfish (Scarus ovifrons), groupers, mackerel (Decapterus macrosoma), and starfish, where tissue concentrations can exceed those in primary vectors by factors leading to elevated risks at higher trophic levels. During Ostreopsis blooms, trace levels of palytoxin are detectable in , often at concentrations reflecting episodic releases from algal cells. Recent advancements in monitoring include liquid chromatography-tandem (LC-MS/MS) methods refined in 2024, which enhance for quantifying palytoxin and analogs in environmental matrices like and non-producing organisms, enabling proactive detection of bioaccumulation risks.

Biological Mechanism

Molecular target

Palytoxin binds with high affinity to the Na⁺/K⁺-ATPase, the primary molecular target responsible for its toxic action, with a (K_d) of approximately 20 pM. This interaction occurs at the extracellular face of the pump's alpha subunit, distinct from but overlapping with the binding site of cardiac glycosides like . Upon binding, palytoxin converts the ATP-driven into a non-selective cation channel, permitting passive influx of Na⁺, K⁺, and Ca²⁺ ions across the plasma membrane. Structural analyses, including recent crystal structures of the palytoxin-bound Na⁺/K⁺-ATPase in the E2P state, demonstrate that the toxin spans the alpha subunit by occupying the physiological Na⁺ exit pathway between transmembrane helices M4 and M6. This positioning prevents closure of the extracellular gate, opening a continuous approximately 7.5 in diameter that traverses the membrane alongside the pump's ion translocation pathway. The binding is non-covalent, allowing reversibility at low toxin concentrations where dissociation can restore pump function. Palytoxin interacts with Na⁺/K⁺-ATPase alpha subunit isoforms, with effects most pronounced in excitable cells such as neurons and muscle cells that predominantly express the α1 isoform.

Cellular and physiological effects

Palytoxin targets the Na+/K+-ATPase pump on cell membranes, converting it into a non-selective cation channel that permits massive Na⁺ influx and K⁺ efflux along their electrochemical gradients. This ion dysregulation causes rapid and sustained membrane depolarization in excitable cells, such as neurons and myocytes. The elevated intracellular Na⁺ concentration subsequently reverses the Na⁺/Ca²⁺ exchanger, leading to Ca²⁺ overload that exacerbates cellular stress. Additionally, the toxin's interference with the pump's normal ATP-dependent transport function contributes to ATP depletion, as the energy required for ion homeostasis is compromised, often through secondary mitochondrial dysfunction. These ionic imbalances trigger secondary effects including hemolysis in erythrocytes, where the loss of K⁺ and gain of Na⁺ create osmotic swelling and eventual cell due to disrupted . In , the Ca²⁺ overload promotes uncontrolled contractures, leading to characterized by muscle fiber breakdown and release of intracellular contents. At the organ level, cardiac effects arise from sarcolemma destabilization, where and Ca²⁺ influx disrupt excitation-contraction , resulting in arrhythmias such as irregular beating and eventual contractile failure in atrial and ventricular tissues. Respiratory muscle occurs through similar mechanisms, with ion dysregulation impairing diaphragmatic and intercostal muscle function, contributing to ventilatory failure. Neurologically, initial excitation manifests as heightened neuronal firing from , but this progresses to failure due to energy depletion and ionic overload, sensitizing cells to excitotoxic damage. Sublethal exposures demonstrate across cell lines, with IC₅₀ values ranging from 0.4 to 18 ng/mL in studies on and intestinal cells, reflecting dose-dependent membrane permeability changes. In neuronal models, such as HT22 cells, palytoxin induces mitochondrial damage including swelling, cristae fragmentation, and loss of , alongside endoplasmic reticulum dilation, which collectively impair cellular viability even at low chronic doses. Recent structural studies (as of 2025) further elucidate how palytoxin in the E2P conformation locks the in an open-channel state, confirming the mechanistic details described.

Toxicity

Lethality and potency metrics

Palytoxin is recognized as one of the most potent non-peptide natural toxins, with (LD<sub>50</sub>) values demonstrating exceptional lethality via parenteral routes. In rabbits, the intravenous LD<sub>50</sub> is 0.025 μg/kg (25 ng/kg). In mice, early studies reported an intravenous LD<sub>50</sub> of 0.15 μg/kg, while later reevaluations indicate intraperitoneal LD<sub>50</sub> values of 0.295–0.68 μg/kg depending on strain and methods. By contrast, oral administration in mice yields a much higher LD<sub>50</sub> of 510–767 μg/kg, highlighting the toxin's reduced through the digestive system. Potency varies by exposure route, with subcutaneous and intratracheal () LD<sub>50</sub> values in ranging from 0.24 to 0.63 μg/kg, comparable to intravenous . Dermal exposure results in lower potency due to the skin's , though specific LD<sub>50</sub> metrics are less precisely defined and generally indicate reduced systemic absorption compared to injection or . These toxicity benchmarks were established in the 1970s through pioneering bioassays, with subsequent studies refining values; palytoxin remains more potent than well-known neurotoxins such as (LD<sub>50</sub> ~8–10 μg/kg intravenously in mice) and (LD<sub>50</sub> ~0.1–0.2 μg/kg subcutaneously in mice).

Factors influencing toxicity

The toxicity of palytoxin exhibits a steep dose-response curve, with non-lethal effects observed below thresholds of approximately 1 ng/mL in various models, such as barrier integrity assays on cells where disruption begins at 0.5 ng/mL but minimal changes occur at lower concentrations. In vivo, the (LD50) in mice varies by route, ranging from 0.045 μg/kg intravenously to 510–767 μg/kg orally, highlighting route-dependent potency where sub-lethal doses induce reversible symptoms like without fatality. Analogues such as demonstrate reduced potency compared to palytoxin, often 10- to 100-fold less toxic depending on the assay and specific congener. For instance, shows approximately 10-fold lower activity in hemolytic and barrier integrity tests, with values around 5–10 ng/mL in cells versus 0.5–2 ng/mL for palytoxin, while is even less potent, exhibiting no barrier disruption up to 5 ng/mL. Environmental factors significantly modulate palytoxin exposure risk, particularly through variability in Ostreopsis blooms where toxin concentrations can reach up to several hundred μg/L in dense cultures, though field measurements during events typically range from 0.01 to 0.35 μg/L for particulate ovatoxin-a. These blooms contribute to in and , amplifying human exposure, while palytoxin remains stable in neutral but degrades under acidic or alkaline conditions, potentially reducing persistence in dynamic environments. Host susceptibility varies by species, with showing route-specific differences—mice are more sensitive to intravenous administration (LD50 0.045 μg/kg) than rats (0.089 μg/kg), though overall oral toxicity is lower in compared to , which exhibit greater cardiovascular vulnerability akin to humans. Age and pre-existing health conditions further influence outcomes, as younger individuals and those with cardiac issues face heightened risk due to palytoxin's disruption of Na+/K+-ATPase leading to myocardial injury and arrhythmias, exacerbating symptoms in patients with underlying heart disease.

Clinical Effects

Symptoms by exposure route

Palytoxin poisoning manifests with distinct clinical symptoms depending on the route of , often beginning with local effects that may progress to systemic involvement. Ingestion. Symptoms typically onset within minutes to several hours and include initial gastrointestinal distress such as , , , and , accompanied by and . Progression can involve , weakness, , , and potentially if untreated. These effects stem from historical cases of contaminated consumption, where metallic taste often precedes the onset. Dermal. Exposure through skin contact, commonly during aquarium handling of zoanthid corals, causes localized pain, , , pruritus, and blistering at the site, sometimes leading to with prolonged contact. and numbness around the exposure area are frequent, with potential for systemic symptoms like fever and if significant absorption occurs. Onset is usually rapid, within minutes to hours. Inhalation. Inhalation of aerosolized palytoxin, often from vapor during coral maintenance, produces respiratory symptoms starting 30 minutes to 2 hours post-exposure, including , , dyspnea, , and fever. These can rapidly escalate to , , wheezing, , and acute . and systemic weakness may accompany the respiratory distress. Ocular. Direct eye exposure, such as from coral dust, results in keratoconjunctivitis with severe pain, photophobia, conjunctival injection, lacrimation, foreign body sensation, and decreased visual acuity. Corneal epithelial defects, chemosis, and periorbital edema are common, as seen in 2024 cases among marine experts handling contaminated corals. Symptoms onset within hours and can lead to temporary vision loss if not promptly irrigated.

Pathophysiological correlations

Palytoxin exerts its cardiotoxic effects by transforming the Na⁺/K⁺-ATPase into a non-selective cation channel, resulting in sodium influx, membrane depolarization, and subsequent calcium overload in cardiomyocytes via the Na⁺/Ca²⁺ exchanger. This calcium dysregulation disrupts excitation-contraction coupling, leading to arrhythmias that manifest as electrocardiographic changes, including , , and fatal dysrhythmias. In , the persistent depolarization induces contracture and breakdown, contributing to characterized by release and elevated levels. Respiratory symptoms arise from palytoxin's induction of through endothelial cell gap formation, causing alveolar hemorrhage and that impairs and leads to dyspnea. Additionally, imbalances disrupt neuromuscular transmission, resulting in respiratory muscle in severe exposures. Neurologically, palytoxin initially causes excitation via and cation influx, manifesting as tremors and due to altered neuronal equilibria. In advanced stages, profound dysregulation can progress to through widespread neuronal dysfunction, myocardial injury, or . Ocular exposure to palytoxin results in corneal endothelial and epithelial damage, leading to keratoconjunctivitis with symptoms of , , and epithelial defects, as documented in case studies from 2021 to 2024. Severe systemic culminates in multi-organ failure, driven by global cellular perturbations affecting cardiac, renal, and hepatic functions.

Treatment

procedures

Decontamination procedures for palytoxin prioritize rapid removal of the to minimize and systemic effects. For dermal , immediate and copious of the affected area with saline or is recommended to dilute and remove the from the skin surface. Similarly, ocular requires prompt with saline or to prevent corneal damage and conjunctival inflammation. These steps should be performed as soon as possible, ideally within minutes of , to reduce local and potential systemic uptake. In cases of inhalation exposure, the primary decontamination involves moving the individual to fresh air to terminate further aerosol inhalation and alleviate respiratory distress. Bronchodilators may be administered via to support airway patency during this process. For gastrointestinal exposure, such as , activated charcoal can be used for if administered within one hour of exposure, as it adsorbs the in the gut to limit absorption. Environmental decontamination, particularly in aquarium settings, focuses on neutralizing palytoxin in water and on surfaces. Corals suspected of releasing the should be soaked in a 0.1% (household ) solution for at least 30 minutes to inactivate the compound. Work surfaces and equipment can be decontaminated with 0.1% or 0.1 N solutions, allowing sufficient contact time for inactivation. In aquariums, filtration effectively adsorbs up to 99.7% of palytoxin from , serving as a key strategy for water cleanup. Recent stability studies indicate that palytoxin degrades in highly aqueous environments, supporting pH adjustments to extremes (e.g., acidic or basic conditions) as an additional inactivation method during cleanup. Following decontamination, supportive medical care should be sought to manage any residual symptoms.

Supportive medical care

There is no specific or antivenin for palytoxin , with focused exclusively on supportive measures to manage symptoms and prevent complications; ongoing research into potential neutralizing agents continues but has not yielded clinical therapies as of 2025. represents the initial step prior to intervention. Cardiovascular support is critical due to the toxin's potential to induce arrhythmias, , and myocardial damage. Appropriate antiarrhythmic agents may be administered for ventricular dysrhythmias based on electrocardiographic (ECG) findings, while vasopressors like norepinephrine are used to counteract severe and maintain . Electrocardiographic monitoring is essential to detect and address these effects promptly. Respiratory complications, including and acute respiratory failure, require aggressive intervention. is indicated for severe cases with hypoxemia or respiratory distress, often supplemented by nebulized beta-agonists and corticosteroids to reduce bronchospasm and . Patients should be monitored intensively for 24 to 48 hours post-exposure to watch for delayed deterioration. Renal failure secondary to is managed with aggressive intravenous fluid resuscitation to promote and prevent ; is employed if or severe imbalances develop. For ocular exposures leading to , topical corticosteroids such as 1% (administered at least six times daily) are used to control , alongside prophylactic topical antibiotics to prevent secondary . Severe cases may necessitate additional interventions like amniotic membrane transplantation. Pain management, particularly for myalgias and severe discomfort from rhabdomyolysis or dermal exposure, involves analgesics such as non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids, titrated to symptom relief.

Poisoning Incidents

Historical mass poisonings

One of the earliest recorded incidents of palytoxin-related seafood poisoning occurred in the of during the 1960s, involving the ingestion of (Alutera scripta), which caused multiple cases of severe illness and one death. The toxin responsible was later identified as palytoxin or a close analog through analysis of fish gut extracts in the 1970s, marking an initial link between the compound and intoxication via contaminated food sources. In , a in 1986 was associated with the consumption of smoked (Decapterus macrosoma), resulting in near-fatal symptoms such as , cardiac arrhythmias, and respiratory distress in affected individuals. These cases were retrospectively attributed to palytoxin contamination, highlighting the toxin's accumulation in planktivorous and its role in clupeotoxism-like syndromes. Additionally, surrounding the "limu-make-o-" (deadly seaweed of ), later identified as the zoanthid Palythoa toxica, underscores early awareness of palytoxin risks, with reports of group exposures affecting up to 10 people through inadvertent ingestion of the toxin-laden coral mistaken for . During the 1990s in , multiple outbreaks of seafood poisoning affected dozens of individuals, with at least two fatalities linked to the ingestion of sardines (Herklotsichthys quadrimaculatus) contaminated with palytoxin-like toxins. These incidents, part of a series of nine documented outbreaks between 1993 and 1996 involving clupeoid and other marine , presented with rapid-onset neurological and cardiovascular symptoms, confirming palytoxin's involvement through toxicological analysis of samples showing hemolytic activity consistent with the . High levels of the compound were also noted in xanthid crabs of the Demania, contributing to the regional of mass intoxications from crab consumption.

Route-specific cases

A near-fatal case of palytoxin in the involved a who developed severe after consuming contaminated crab, characterized by muscle pain, weakness, and requiring ; the individual survived after prolonged intensive care but experienced lingering for weeks. Similar cases from xanthid crabs in the have historically shown rapid onset of bitter taste, , , and muscle cramps leading to renal failure, with toxin levels in crabs reaching 0.8 mg/g tissue. Skin contact with palytoxin-laden during in the led to localized in exposed areas, with one documented incident involving a diver who developed painful ulcers and tissue sloughing at the site of abrasion from species, accompanied by systemic symptoms like numbness and ; treatment involved wound and supportive care, with full recovery after several months. Dermal absorption through cuts allows the to bind Na+/K+-ATPase pumps, causing local ischemia and due to and membrane depolarization. During a 2012 Ostreopsis bloom along beaches, over 50 beachgoers experienced exposure to aerosolized palytoxin-like compounds, presenting with respiratory symptoms including , , dyspnea, and within hours of exposure; most cases were mild and self-limiting, but some required bronchodilators and resolved within days without long-term effects. routes typically provoke of mucous membranes, with toxin concentrations in aerosols estimated at 1-10 ng/m³ during blooms. Ocular exposure to palytoxin occurred in a 2021 case when an individual handling zoanthid developed , manifesting as severe eye pain, , corneal , and epithelial defects confirmed by slit-lamp exam; symptoms emerged within 24 hours, treated with topical corticosteroids and antibiotics, leading to resolution over two weeks without vision loss. Ocular contact induces rapid via toxin-induced ion imbalance in corneal cells, often mimicking chemical burns. A mixed exposure incident in 1994 involved a family in exposed to palytoxin via splashed aquarium water containing zoanthids, resulting in multiple members experiencing a combination of dermal irritation, ocular burning, and mild respiratory distress; symptoms included , , and throat irritation, all resolving with within 48 hours. Such cases highlight the toxin's versatility across routes, with low doses (sub-ng/kg) sufficient for mild systemic effects in vulnerable individuals.

Recent aquarium exposures

In May 2020, a family in the United States suffered respiratory distress following exposure to palytoxin aerosolized during the of zoanthid corals in their . The exposure occurred when the father used hot water to remove the corals, generating steam that released the toxin; his wife and daughter experienced secondary exposure in the enclosed space. Symptoms included severe (respiratory rate exceeding 40 breaths per minute), (oxygen saturation as low as 80% on room air), fever, gastrointestinal upset, and , with bilateral ground-glass opacities visible on chest imaging for all three family members, necessitating hospitalization during the early when symptoms mimicked viral illness. In 2023, two individuals in developed dermal and ocular symptoms after handling a home aquarium containing Ostreopsis cf. ovata, a producer of ovatoxins—palytoxin analogs. Exposure likely occurred through direct skin contact and aerosolized water during tank maintenance, resulting in eye irritation, , skin rashes, and mild respiratory discomfort consistent with known effects of these toxins in confined aquatic environments. Analysis of similar cases has confirmed ovatoxin presence in aquarium , highlighting the risk from benthic microalgae in hobbyist setups. From 2024 to 2025, reports of palytoxin exposures from home aquariums have increased , driven by the rising popularity of zoanthid corals among hobbyists, with control centers noting a surge in consultations related to and dermal contact during routine maintenance. According to center data, palytoxin exposure calls increased by approximately 94% from pre-pandemic levels (2015-2019) to post-pandemic (2020-2023), with continued rises noted into 2024-2025. This trend underscores emerging risks in the marine aquarium community, where inadequate ventilation and lack of (PPE), such as gloves and respirators, exacerbate exposures; recommendations emphasize improved tank handling protocols, including outdoor cleaning and decontamination where applicable, to mitigate these incidents.

References

  1. [1]
    History and Toxinology of Palytoxins - PMC - PubMed Central
    Palytoxins are a group of highly potent and structurally complex marine toxins that rank among some of the most toxic substances known to science.
  2. [2]
    Palytoxin and Analogs: Biological and Ecological Effects - PMC
    PTX and its analogs are potent marine toxins known to cause fatality of several animals, including humans.
  3. [3]
    Palytoxin - an overview | ScienceDirect Topics
    Palytoxin is one of most potent marine toxins known. It was isolated first from corals located in the South Pacific.
  4. [4]
    Palytoxin: A New Marine Toxin from a Coelenterate - Science
    Palytoxin: A New Marine Toxin from a Coelenterate. Richard E ... HASHIMOTO, Y, BULLETIN OF THE JAPANESE SOCIETY FOR THE SCIENCE OF FISH 35: 1086 (1969).
  5. [5]
    Human risk associated with palytoxin exposure - ScienceDirect.com
    Recent evidence also suggests that humans are negatively impacted through PTX exposure by inhalation and dermal routes. Continued research into the distribution ...Toxins · Toxicity · Palytoxin Exposure Risks...
  6. [6]
    [PDF] Review of Clupeotoxism, an Often Fatal Illness from the ...
    Halstead (1967:610) listed 87 references dealing with clupeoid poisoning. He con- cluded with the following statement, ''It is noteworthy that to date no one ...
  7. [7]
    Studies on the origin and distribution of palytoxin in a Caribbean ...
    Hashimoto et al., 1969. Y Hashimoto, N Fusetani, S Kimura. Aluterin: a toxin of filefish, Alutera scripta, probably originating from a zoantharian Palythoa ...
  8. [8]
  9. [9]
  10. [10]
    Further studies on palytoxin. II. structure of palytoxin - ScienceDirect
    Abstract. The full structure of palytoxin, a potent coelenterate toxin, is reported.
  11. [11]
    Total synthesis of palytoxin carboxylic acid and palytoxin amide
    The total synthesis of Brevetoxin B: A twelve‐year odyssey in organic synthesis. Angewandte Chemie International Edition in English 1996, 35 (6) , 588-607.
  12. [12]
  13. [13]
    Palytoxin: The danger hidden in tropical aquariums - C&EN
    Jan 10, 2018 · Palytoxin is gargantuan, weighing in at 2,680 daltons, and it has a backbone 115 carbon atoms long. It is one of the longest continuous ...
  14. [14]
  15. [15]
    Palytoxins: Biological and chemical determination - ScienceDirect.com
    Mar 1, 2011 · PLTX shows remarkable biological activity even at very low concentration (Moore and Scheuer, 1971). Lethal doses of PLTX through intravenous ...Missing: pharmacological | Show results with:pharmacological
  16. [16]
    Palytoxin - an overview | ScienceDirect Topics
    Halstead (1967) reviewed this and other cases (87 in total) of clupeoid ... Death may occur in less than 15 min.” Fatal clupeoid fish poisoning events ...
  17. [17]
    [DOC] “Palytoxins: Biological and Chemical determination” - Digital CSIC
    Hashimoto, Y., N. Fusetani and S. Kimura; 1969. Aluterin: a toxin of Filefish, Alutera scripta, probably originated from a zoantharian, Palythoa tuberculosa.
  18. [18]
    Stability and Recovery of Palytoxin and Ovatoxin-a
    ### Summary of Palytoxin Stability in Methanol or Solvents
  19. [19]
    Recommended clean-up procedures following palytoxin incidents
    Apr 1, 2024 · Palytoxin is a toxin produced by species of soft corals called zoantharians. They are popular with marine reef aquarists as they are very ...
  20. [20]
    Scientific Opinion on marine biotoxins in shellfish – Palytoxin group
    The basic molecule consists of a long, partially unsaturated aliphatic backbone containing cyclic ethers, 64 chiral centers, 40-42 hydroxyl and 2 amide groups ( ...
  21. [21]
    Palytoxin Found in Palythoa sp. Zoanthids (Anthozoa, Hexacorallia ...
    Apr 4, 2011 · Zoanthids (Anthozoa, Hexacorallia) are colonial anemones that contain one of the deadliest toxins ever discovered, palytoxin (LD 50 in mice 300 ng/kg).
  22. [22]
    Complex Toxin Profile of French Mediterranean Ostreopsis cf. ovata ...
    Ostreopsis cf. ovata produces palytoxin analogues including ovatoxins (OVTXs) and a putative palytoxin (p-PLTX), which can accumulate in marine organisms ...
  23. [23]
    Putative Palytoxin and Its New Analogue, Ovatoxin-a, in Ostreopsis ...
    Nov 7, 2007 · The present paper provides further insights into the toxin profile of the Mediterranean O. ovata. The reported results confirmed the presence of ...
  24. [24]
    First Evidence of Palytoxin and 42-Hydroxy-palytoxin in the Marine ...
    Mar 31, 2011 · Palytoxins and analogues: Ecobiology and origin, chemistry, metabolism and chemical analysis. In: Botana LM, editor. Phycotoxins: Chemistry ...
  25. [25]
    Ecotoxicological Impact of the Marine Toxin Palytoxin on the ... - NIH
    Jan 18, 2022 · Considering the increasing frequency of Ostreopsis blooms due to global warming, PLTX was investigated for its effects on Artemia ...Missing: oceans 2020s
  26. [26]
    [PDF] Fabri-Ruiz et al. - 2024 - Harmful Ostreopsis cf. ovata blooms .pdf
    Jul 11, 2024 · Ocean warming since 1982 has expanded the niche of toxic algal blooms in the North Atlantic and North Pacific oceans. Proc. Natl. Acad. Sci ...<|separator|>
  27. [27]
    Ovatoxin-a and Palytoxin Accumulation in Seafood in Relation to ...
    The total content accumulated in urchins reached 450 µg PLTX eq/kg total flesh (summer 2008). In mussels, the maximum was 230 µg eq PLTX/kg (summer 2009) ...
  28. [28]
    Study on Palytoxin Contamination in Korean Shellfish Using LC/MS ...
    Aug 6, 2025 · Study on Palytoxin Contamination in Korean Shellfish Using LC/MS/MS Analysis. October 2024; Journal of Food Hygiene and Safety 39(5):429-435.
  29. [29]
    Enhanced Chromatographic Separation for Quantitative Accuracy of ...
    The analysis of PlTX using liquid chromatography-tandem mass spectrometry (LC/MS/MS) has become a preferred method due to its high sensitivity and specificity.Missing: seawater blooms
  30. [30]
    Palytoxin: Membrane mechanisms of action
    **Summary of Palytoxin Mechanisms (https://www.sciencedirect.com/science/article/abs/pii/S0041010109001457):**
  31. [31]
    Palytoxin acts through Na+, K+-ATPase - ScienceDirect.com
    It centers on the hypothesis that palytoxin binds to Na+,K+-ATPase and converts the enzyme or its close vicinity into an open channel with the permselectivity ...
  32. [32]
    Palytoxin action on the Na(+),K(+)-ATPase and the disruption of ion ...
    Mar 1, 2011 · Palytoxin binds to Na(+),K(+)-ATPase, converting it into a non-selective cation channel, disrupting ion homeostasis by allowing passive ion ...
  33. [33]
    9VJ2: Crystal structure of palytoxin-bound Na+,K+-ATPase in the ...
    Oct 1, 2025 · Palytoxin (PTX), a potent marine toxin, has long been known to transform Na + ,K + -ATPase (NKA), an indispensable ion pump, ...Missing: covalent reversible
  34. [34]
    In Vitro Cell Sensitivity to Palytoxin Correlates with High Gene ...
    Aug 14, 2020 · This toxicogenetic study represents the first approach to define genetic risk factors that may influence the onset of adverse effects in human PLTX poisonings.
  35. [35]
  36. [36]
  37. [37]
    [PDF] Toxicity of palytoxin, purified ovatoxin-a, ovatoxin-d ... - HAL- Anses
    Jul 22, 2024 · A study on HaCaT keratinocytes concluded that purified OVTX-a was 100-fold less potent to induce cytotoxicity (IC50 = 1.1 µM) than PlTX (IC50 = ...
  38. [38]
    History and Toxinology of Palytoxins - MDPI
    The detection of palytoxin in edible fish was first reported in 1969, when gut extracts of the filefish Altera scripta were found to contain fragments of a ...
  39. [39]
  40. [40]
    Sea-Air Transfer of Ostreopsis Phycotoxins Is Driven by the ...
    Oct 12, 2024 · Particulate OVTX-a concentrations ranged from 0.06 to 0.35 μg L–1 in the SML and from 0.01 to 0.04 μg L–1 in the SW (Table S4). No dissolved ...
  41. [41]
    Palytoxin disrupts cardiac excitation-contraction coupling through ...
    The suggested mode of palytoxin toxicity in the atrium involves the conversion of Na+-K+ pumps into nonselective cation channels as a primary event followed by ...
  42. [42]
    Coral Toxicity - StatPearls - NCBI Bookshelf
    Aug 7, 2023 · Coral toxicity, specifically caused by palytoxin, is a serious condition resulting from exposure to certain species of soft corals, such as Zoanthid corals.Missing: organisms | Show results with:organisms
  43. [43]
    Palytoxin Toxicity During Home Marine Aquarium Maintenance
    Seizures and cardiotoxicity caused death in three patients with laboratory-proven PTX ingestions [Citation5,Citation6]. Topical absorption with subsequent ...
  44. [44]
    Palytoxin-induced acute respiratory failure - PMC - NIH
    Oct 21, 2016 · Common symptoms include numbness, paraesthesia and swelling around the site of exposure (cutaneous exposure), rhinorrhea, cough, dyspnea ( ...Missing: arrhythmias neurological
  45. [45]
    Coral Crisis: Palytoxin-Induced Keratoconjunctivitis in Marine Experts
    Oct 28, 2024 · Outlined in Figure 3, palytoxin has a large molecular structure with 64-isolate chiral centers making it both very lipophilic, hydrophilic, and ...Missing: properties | Show results with:properties
  46. [46]
    Coral Keratitis: Case Report and Review of Mechanisms of Action ...
    Jan 12, 2021 · Palytoxin is one of the most lethal natural toxins ever discovered. This molecule has been isolated from various marine animals, including ...
  47. [47]
    Palytoxin disrupts cardiac excitation-contraction coupling ... - PubMed
    Palytoxin is a coral toxin that seriously impairs heart function, but its effects on excitation-contraction (E-C) coupling have remained elusive.Missing: arrhythmias | Show results with:arrhythmias
  48. [48]
    Pharmacological and biochemical studies of cytotoxicity of ...
    Apr 17, 1989 · Vascular leakage was due to gap formation between endothelial cells. Similarly, endothelial cells cultured from pig pulmonary artery lost their ...<|control11|><|separator|>
  49. [49]
    Palytoxin Keratitis - StatPearls - NCBI Bookshelf
    Palytoxin (PTX) is a large naturally occurring toxin initially isolated from zoanthids (i.e., soft corals) in the genus Palythoa and has since been found in ...
  50. [50]
    Palytoxin: A potent but poorly understood marine toxin found on ...
    Oct 30, 2019 · Palytoxin (PLTX) is a potent but poorly understood marine toxin that periodically attracts media attention when poisonings occur.
  51. [51]
    Activated Charcoal - StatPearls - NCBI Bookshelf - NIH
    When the dose of the ingested toxin is known, experts recommend activated charcoal at a 10 to 1 ratio of activated charcoal to the ingested toxin. This ratio ...Missing: palytoxin | Show results with:palytoxin
  52. [52]
    Suspected Palytoxin Inhalation Exposures Associated with Zoanthid ...
    Aug 14, 2015 · Palytoxin is a potentially life-threatening toxin that can act via dermal, inhalation, and oral routes of exposure. Marine aquarium hobbyists ...Missing: paralysis | Show results with:paralysis
  53. [53]
    Biological Safety Manual - Chapter 08 - UNC Policies
    Solutions of sodium hypochlorite (0.1%) or sodium hydroxide (0.1N) readily inactivate the toxin and are recommended for decontamination of work surfaces and for ...
  54. [54]
    An aquarium hobbyist poisoning: Identification of new palytoxins in ...
    Palytoxin (PLTX) is a lethal natural toxin often found in Palythoa zoantharians that, together with its congeners, may induce adverse effects in humans ...
  55. [55]
    [PDF] Palytoxin-Containing Aquarium Soft Corals as an Emerging Sanitary ...
    Feb 4, 2016 · Structural studies demonstrated that PLTX assumes a dimeric form in aqueous solution, acquiring a form of 8, measuring 52.3 ˆ 22.0 ˆ 15.1 Å [13] ...
  56. [56]
    A highly toxic substance extracted from the Zoanthid, Palythoa ...
    Abstract-Palytoxin (PTX), the most potent marine toxin isolated from the Zoanthid, ... poisoning by a filefish,. Alutera scripta, in the Ryukyu Islands (1). On ...
  57. [57]
    Clinical and laboratory findings implicating palytoxin as cause of ...
    A near fatal case of ciguatera-related intoxication following consumption of smoked Decapterus macrosoma is documented. In addition to some of the hallmark ...
  58. [58]
    Identification of putative palytoxin as the cause of clupeotoxism
    In 1994 in Madagascar a woman died after eating a sardine, Herklotsichthys quadrimaculatus. Two heads removed, respectively, from a toxic and a nontoxic ...Missing: historical cases
  59. [59]
    Intoxication by marine animal venoms in Madagascar ... - PubMed
    From July 1993 to May 1996, nine seafood poisoning outbreaks occurred in coastal villages after turtle, shark and sardine meals.Missing: clupeotoxism | Show results with:clupeotoxism
  60. [60]
    Rhabdomyolysis and myocardial damage induced by palytoxin, a ...
    A 55-year-old man had rhabdomyolysis and myocardial damage induced by palytoxin. Weakness and myalgia of four extremities occurred five hours after eating a ...Missing: mechanism | Show results with:mechanism
  61. [61]
    Human fatality due to ingestion of the crab Demania reynaudii that ...
    The causative toxin was suggested to be palytoxin on the basis of dose-death time relationships and chromatographic properties. Publication types. Case Reports ...Missing: Madagascar 1990s
  62. [62]
    Ostreopsis cf. ovata Bloom in Currais, Brazil: Phylogeny, Toxin ... - NIH
    Jul 27, 2019 · Interestingly, recurrent intoxication episodes have also been reported during summer among beach users in the northeastern coast of Brazil ( ...
  63. [63]
    Palytoxin toxicology: Animal studies - ScienceDirect.com
    Early studies showed that palytoxin is exceptionally toxic to animals when injected (Wiles et al., 1974). ... LD50 in the latter species are reported. The ...Missing: LD50 | Show results with:LD50
  64. [64]
    Coral Keratitis: Case Report and Review of Mechanisms of Action ...
    Jan 12, 2021 · Cutaneous exposure to palytoxin is likely the most common route of exposure, since handling the organism can result in epidermal exposure.
  65. [65]
    Coral Keratitis: Case Report and Review of Mechanisms of Action ...
    Jan 12, 2021 · In this review, we discuss a case of systemic toxicity from inhalation and ocular exposure to presumed palytoxin on a zoanthid coral.Missing: US | Show results with:US<|control11|><|separator|>
  66. [66]
    COVID or Coral? A Case Report - EMRA
    Aug 17, 2020 · Though exceedingly rare, inhalation can cause respiratory distress and even respiratory failure. The irritant properties of palytoxin are ...Missing: CDC | Show results with:CDC
  67. [67]
    Toxicity of palytoxin, purified ovatoxin-a, ovatoxin-d and extracts of ...
    Overall, OVTX-d was shown to be less toxic than OVTX-a and PlTX. Therefore, oral exposure to OVTX-a and -d could provoked lower acute toxicity than PlTX.